Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
enoxaparin (lovenox) (1 trial)
Digestive System Neoplasms (Phase 4)
Gastrointestinal Neoplasms (Phase 4)
Thromboembolism (Phase 4)
Trials (1 total)
Trial APIs (1 total)